EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SMAP29: an antibacterial peptide that possesses anti-inflammatory and fast bactericidal actions against colistin-resistant gram-negative bacteria

Ziyue Zeng, Mengjie Wei, Deyi Zhao, Huijing Zhou, Endian Sun, Xiaowei Lv, Yuhan Yang, Tieli Zhou iD, Chunquan Xu iD

Microbiology Spectrum · 02.06.2026 · 14 (6)

DOI: 10.1128/spectrum.02808-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, erschienen am 02.06.2026. Verfasst von Ziyue Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University; Key Laboratory of Clinical Laboratory Diagnosis and T…. Hauptthemen laut MEDLINE: Colistin, Anti-Bacterial Agents, Gram-Negative Bacteria, Anti-Inflammatory Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug-resistant (MDR) gram-negative bacteria (GNB) are threatening global public health. Since colistin (COL) is the last resort antibiotic for MDR gram-negative infections, the rise in colistin-resistant ‌(COL-R) bacteria could pose risks to people. The current research investigation explored the antimicrobial, anti-biofilm, and anti-inflammatory capacities of SMAP29, a naturally generated cationic antibacterial peptide, against clinical COL-R Klebsiella pneumoniae , Pseudomonas aeruginosa , Escherichia coli , Acinetobacter baumannii , and explored its antibacterial mechanisms. The results demonstrated that SMAP29 exhibited a very low minimum inhibitory concentration against COL-R GNB and rapidly killed bacteria within 30 min. In addition, SMAP29 inhibited biofilm growth and eliminated it. According to another study’s findings, SMAP29 could lead to the membrane’s integrity being wiped out, which could result in the formation of intracellular reactive oxygen species. Moreover, SMAP29 could effectively prevent RAW 264.7 macrophages in mice from generating the pro-inflammatory cytokines TNF-α, IL-6, and IL-1β. Assays for cytotoxicity and hemolysis in vitro revealed that SMAP29 proved safe at the tested concentrations. In vivo experiments further demonstrated that the amount of bacteria in the infected mice’s thighs was significantly reduced through SMAP29 treatment. Collectively, our findings demonstrate that SMAP-29’s efficacy stems from its dual action: rapid bactericidal activity via lipopolysaccharide-mediated membrane disruption and concurrent anti-inflammatory effects. This multifaceted potency, validated both in vitro and in vivo , positions SMAP-29 as a promising therapeutic candidate against multidrug-resistant bacterial infections. IMPORTANCE Multidrug-resistant gram-negative bacteria have emerged as critical threats to global public health, driving intractable infections with steadily rising incidence. These pathogens exhibit formidable tolerance to virtually all classes of contemporary antibiotics, translating into persistently high mortality and formidable clinical challenges. This study elucidates the antibacterial, anti-biofilm, and anti-inflammatory activities of the antimicrobial peptide SMAP-29 against colistin-resistant gram-negative organisms while dissecting its underlying mechanisms. Our findings provide a mechanistic framework and a promising therapeutic avenue for combating multidrug-resistant infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColistinAnti-Bacterial AgentsGram-Negative BacteriaAnti-Inflammatory AgentsAntimicrobial PeptidesAntimicrobial Cationic PeptidesAnimalsMiceMicrobial Sensitivity TestsRAW 264.7 CellsBiofilmsDrug Resistance, Multiple, BacterialHumansGram-Negative Bacterial InfectionsMacrophagesCytokinesAcinetobacter baumanniiBlood ProteinsCathelicidins

Stichwörter der Autor:innen

SMAP29antimicrobial peptidecolistingram-negative bacteriamultidrug-resistant

Substanzen

ColistinAnti-Bacterial AgentsAnti-Inflammatory AgentsSMAP29 protein, Ovis ariesAntimicrobial PeptidesAntimicrobial Cationic PeptidesCytokinesBlood ProteinsCathelicidins

Autor:innen und Institutionen

  • Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University; Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou, Zhejiang, China.
  • School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou, China.

ORCID-Profile: Tieli Zhou, Chunquan Xu

Zitieren

APA

Zeng, Z., Wei, M., Zhao, D., Zhou, H., Sun, E., Lv, X., Yang, Y., Zhou, T., & Xu, C. (2026). SMAP29: an antibacterial peptide that possesses anti-inflammatory and fast bactericidal actions against colistin-resistant gram-negative bacteria. Microbiology Spectrum, 14(6). https://doi.org/10.1128/spectrum.02808-25

Vancouver

Zeng Z, Wei M, Zhao D, Zhou H, Sun E, Lv X, et al. SMAP29: an antibacterial peptide that possesses anti-inflammatory and fast bactericidal actions against colistin-resistant gram-negative bacteria. Microbiology Spectrum. 2026;14(6). doi:10.1128/spectrum.02808-25

BibTeX
@article{Zeng2026,
  author = {Zeng, Ziyue and Wei, Mengjie and Zhao, Deyi and Zhou, Huijing and Sun, Endian and Lv, Xiaowei and Yang, Yuhan and Zhou, Tieli and Xu, Chunquan},
  title = {SMAP29: an antibacterial peptide that possesses anti-inflammatory and fast bactericidal actions against colistin-resistant gram-negative bacteria},
  journal = {Microbiology Spectrum},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1128/spectrum.02808-25}
}
Kostenlos starten →